Výsledky vyhledávání - "Bonifacio Dewasse"

Activity of Telavancin against Staphylococci and Enterococci Determined by MIC and Resistance Selection Studies

Autor: Peter C. Appelbaum, Linda Beachel, Klaudia Kosowska-Shick, Glenn A. Pankuch, Pamela McGhee, Catherine Clark, Bonifacio Dewasse

Publikováno v: Antimicrobial Agents and Chemotherapy. 53:4217-4224

This study used CLSI broth microdilution to test the activity of telavancin and comparator antimicrobial agents against 67 methicillin (meticillin)-resistant Staphylococcus aureus (MRSA) isolates. Twenty-six vancomycin-intermediate S. aureus (VISA) s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9070542f393131c76bc1dabc784337a3
https://doi.org/10.1128/aac.00742-09

Zobrazit plný text záznamu

Resistance Selection Studies Comparing the Activity of Razupenem (PTZ601) to Vancomycin and Linezolid against Eight Methicillin-Resistant and Two Methicillin-Susceptible Staphylococcus aureus Strains

Autor: Linda Beachel, Catherine Clark, Pamela McGhee, Peter C. Appelbaum, Bonifacio Dewasse, Klaudia Kosowska-Shick

Publikováno v: Antimicrobial Agents and Chemotherapy. 53:3118-3121

Multistep and single-step resistance selection studies were performed with razupenem, linezolid, and vancomycin against 10 methicillin (meticillin)-resistant and -susceptible Staphylococcus aureus strains. After 20 daily subcultures, razupenem yielde

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f29b7e6e1444575b15642ba8f27281b
https://doi.org/10.1128/aac.00183-09

Zobrazit plný text záznamu

In Vitro Activity of DC-159a, a New Broad-Spectrum Fluoroquinolone, Compared with That of Other Agents against Drug-Susceptible and -Resistant Pneumococci

Autor: Kathy Smith, Lois M. Ednie, Catherine Clark, Tatiana Bogdanovich, Bonifacio Dewasse, Pamela McGhee, Peter C. Appelbaum

Publikováno v: Antimicrobial Agents and Chemotherapy. 52:77-84

DC-159a yielded MICs of ≤1 μg/ml against 316 strains of both quinolone-susceptible and -resistant pneumococci (resistance was defined as a levofloxacin MIC ≥4 μg/ml). Although the MICs for DC-159a against quinolone-susceptible pneumococci were

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::795061f5123753713deb91b8cfd087c2
https://doi.org/10.1128/aac.01229-07

Zobrazit plný text záznamu

Antipneumococcal Activity of DW-224a, a New Quinolone, Compared to Those of Eight Other Agents

Autor: Bonifacio Dewasse, Pamela McGhee, Peter C. Appelbaum, Gengrong Lin, Klaudia Kosowska-Shick, Bülent Bozdogan, Dong-Rack Choi, Glenn A. Pankuch, Jei Man Ryu, Kim L. Credito

Publikováno v: Antimicrobial Agents and Chemotherapy. 50:2064-2071

DW-224a is a new broad-spectrum quinolone with excellent antipneumococcal activity. Agar dilution MIC was used to test the activity of DW-224a compared to those of penicillin, ciprofloxacin, levofloxacin, gatifloxacin, moxifloxacin, gemifloxacin, amo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a3196c9199e31308e197e4069131724
https://doi.org/10.1128/aac.00153-06

Zobrazit plný text záznamu

Antipneumococcal Activity of Ceftobiprole, a Novel Broad-Spectrum Cephalosporin

Autor: Catherine Clark, Gengrong Lin, Bülent Bozdogan, Bonifacio Dewasse, Kim L. Credito, Klaudia Kosowska, Stuart Shapiro, Dianne B. Hoellman, Pamela McGhee, Peter C. Appelbaum

Publikováno v: Antimicrobial Agents and Chemotherapy. 49:1932-1942

Ceftobiprole (previously known as BAL9141), an anti-methicillin-resistant Staphylococcus aureus cephalosporin, was very highly active against a panel of 299 drug-susceptible and -resistant pneumococci, with MIC 50 and MIC 90 values (μg/ml) of 0.016

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2f753d4aa760727048322150c31f578
https://doi.org/10.1128/aac.49.5.1932-1942.2005

Zobrazit plný text záznamu

Activities of Two Novel Macrolides, GW 773546 and GW 708408, Compared with Those of Telithromycin, Erythromycin, Azithromycin, and Clarithromycin against Haemophilus influenzae

Autor: Michael R. Jacobs, Dianne B. Hoellman, Pamela McGhee, Glenn A. Pankuch, Catherine Clark, Gengrong Lin, Klaudia Kosowska, Kim L. Credito, Peter C. Appelbaum, Bonifacio Dewasse

Publikováno v: Antimicrobial Agents and Chemotherapy. 48:4113-4119

The MIC at which 50% of strains are inhibited (MIC 50 ) and the MIC 90 of GW 773546, a novel macrolide, were 1.0 and 2.0 μg/ml, respectively, for 223 β-lactamase-positive, β-lactamase-negative, and β-lactamase-negative ampicillin-resistant Haemop

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af6f66be8b375744feb762e775358e4d
https://doi.org/10.1128/aac.48.11.4113-4119.2004

Zobrazit plný text záznamu

In vitro selection of resistance in haemophilus influenzae by 4 quinolones and 5 β-lactams

Autor: Pamela McGhee, Klaudia Kosowska, Michael R. Jacobs, Bonifacio Dewasse, Peter C. Appelbaum, Bülent Bozdogan, Catherine Clark, Kim L. Credito

Publikováno v: Diagnostic Microbiology and Infectious Disease. 49:31-36

We tested abilities of ciprofloxacin, levofloxacin, gatifloxacin, moxifloxacin, amoxicillin, amoxicillin/clavulanate, cefixime, cefpodoxime, and cefdinir to select resistant mutants in 5 beta-lactamase positive and 5 beta-lactamase negative Haemophil

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8db8a474c17e2ffa17b54272024286d6
https://doi.org/10.1016/j.diagmicrobio.2003.12.001

Zobrazit plný text záznamu

In Vitro Selection of Resistance in Haemophilus influenzae by Amoxicillin-Clavulanate, Cefpodoxime, Cefprozil, Azithromycin, and Clarithromycin

Autor: Bülent Bozdogan, Bonifacio Dewasse, Catherine Clark, Peter C. Appelbaum, Mihaela Perić, Michael R. Jacobs

Publikováno v: Antimicrobial Agents and Chemotherapy. 46:2956-2962

Abilities of amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin to select resistant mutants of Haemophilus influenzae were tested by multistep and single-step methodologies. For multistep studies, 10 random strains were

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a457cc13bd31436bd830ed9d5a92c5d
https://doi.org/10.1128/aac.46.9.2956-2962.2002

Zobrazit plný text záznamu

Single- and multi-step resistance selection study of gemifloxacin compared with trovafloxacin, ciprofloxacin, gatifloxacin and moxifloxacin in Streptococcus pneumoniae

Autor: Peter C. Appelbaum, Michael R. Jacobs, Kensuke Nagai, Todd A. Davies, Bonifacio Dewasse

Publikováno v: Journal of Antimicrobial Chemotherapy. 48:365-374

The ability of sequential subcultures in subinhibitory concentrations of gemifloxacin, trovafloxacin, ciprofloxacin, gatifloxacin and moxifloxacin to select resistant mutants was studied in 16 pneumococci [eight with ciprofloxacin MICs (mg/L) 0.25-1;

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::865ba3136380cc2b1f50f12d19cd63ef
https://doi.org/10.1093/jac/48.3.365

Zobrazit plný text záznamu

In vitro development of resistance to ceftriaxone, cefprozil and azithromycin in Streptococcus pneumoniae

Autor: Glenn A. Pankuch, Peter C. Appelbaum, Michael R. Jacobs, Todd A. Davies, Bonifacio Dewasse, Kensuke Nagai

Publikováno v: Journal of Antimicrobial Chemotherapy. 46:909-915

Approval of ceftriaxone for the treatment of otitis media has led to fear of selection of resistant mutants owing to widespread use. To test this, we examined the ability of sequential subcultures in sub-MICs of ceftriaxone, cefprozil and azithromyci

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27ef09e74390baa077d45931ea2ad17d
https://doi.org/10.1093/jac/46.6.909

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání